NCT01247207Phase 3Terminated

Study of Ataluren in Previously Treated Participants With Nonsense Mutation Dystrophinopathy (nmDBMD)

Study sponsor: PTC Therapeutics

Primary completion is the date data collection ends for the main study measures, not when results are published.

Primary completion2026-02-10Actual
Enrollment · participants265Actual
Source updated2026-10-08Last update listed in the registry record

Changes to this trial

Last 12 months
Filters
Clear filters

· 4 fields changed

Main study measure wording changed

Text changed; whether the study measures changed has not been verified. Saved text may be shortened.

Before: Measure: Number of Participants With Adverse Events Time frame: Baseline up to end of study (up to approximately 8 years) Measure: Number of Participants With Laboratory Parameters Abnormalities Description: Laboratory parameters include hematological, serum biochemistry, adrenal laboratories, and urine data. Time frame: Baseline up to end of study (up to approximately 8 years) Measure: Number of Participants With Abnormal Physical Findings Description: Physical findings include weight, physical examination data, systolic and diastolic blood pressure, radial pulse rate, and body temperature. Time frame: Baseline up to end of study (up to approximately 8 years). After: Measure: Number of Participants With Treatment-emergent Adverse Events (TEAEs) Description: An adverse event (AE) was any untoward medical occurrence in a participant who received study drug without regard to possibility of causal relationship. A TEAE was defined as an AE that occurred or worsened on or after the first dose of ataluren and up to 4 weeks after the last dose of ataluren. A summary of other non-serious AEs and all SAEs, regardless of causality is located in the 'Reported AE section'. Time frame: Baseline up to end of study (up to approximately 15 years).

Participant count type changed

Before: Estimated. After: Actual.

Enrollment · participant count changed

Before: 270 participants (planned). After: 265 participants (actual).

Recruitment status changed

Before: Completed. After: Terminated.

Check registry source

· 3 fields changed

Completion date type changed

Before: Estimated. After: Actual.

Primary completion date changed

Before: 30 Apr 2025. After: 10 Feb 2026.

Recruitment status changed

Before: Enrolling by invitation. After: Completed.

Check registry source

Explore older trial changes

Upgrade to Pro to see the full available history for this trial.

Upgrade to Pro Illustrative preview